A fat substitute is a food product with the same functions, stability, physical, and chemical characteristics as regular fat, with fewer Calories per gram than fat. They are utilized in the production of low fat and low calorie foods.
Fat is present in most foods. It provides a unique texture, flavor, and aroma to the food it is found in. While fat is essential to life, it can be detrimental to health when consumed in excess of physiological requirements. High fat diets increase risk of heart disease, weight gain, and some cancers. High blood cholesterol is more prevalent in those that consume diets high in saturated fats, and it increases risk for coronary heart disease in those individuals. The use of fat substitutes in food products allows for maintenance of the food’s original quality characteristics without the associated risks of fat consumption. In the absence of energy-dense fat molecules, products utilizing fat substitutes are generally lower in calories than their full-fat counterparts.
|Category||Type and example||Function|
|Carbohydrate-based||Binder, body, bulk, flavor, moisture retention, mouth feel|
|Protein-based||Mouth feel, water-binding, reduce syneresis|
|Fat-based||Emulsion, mouth feel|
||Flavour, texture, mouth feel, water retention|
Figure 1: Categories of fat substitutes based on composition. Like fat itself, such compounds have a variety of functions in food products. Table adapted from the American Dietetic Association’s 2005 report on fat replacers.
Consumption of fat substitutes can assist in lowering total overall fat and calorie intake from foods. This has positive implications for those looking to reduce either one of these, especially when in a disease state associated with high fat diets. While fat substitution alone can reduce the percentage of kilocalories ingested from dietary fat, it may not reduce an individual’s total energy intake (in terms of kilocalories) unless the rest of the diet is of high quality and low energy density.
Few concerns have been raised about the safety of fat substitutes. Carrageenan, olestra, and polydextrose have been approved by the U.S. Food and Drug Administration (FDA) for use as food additives, a title which requires both intensive testing over a wide demographic and the ability to meet strict, pre-determined, FDA criteria. Other products, such as guar gum and maltodextrose, are "Generally Recognized as Safe (GRAS)" by the FDA; this is also based on scientific testing and long-term consumption by a variety of consumer demographics. With excessive use, polydextrose can have a laxative effect, and olestra may cause loss of fat-soluble vitamins in the form of fatty stools and is liquid at body temperature. Esterified propoxylated glycerol (EPG), which is a solid at body temperature, achieved GRAS status for confectionery uses in November, 2015. EPG's GRAS status expanded to use at levels up to 38 percent by weight in baked goods and baking mixes, frozen dairy desserts and mixes, grain products and pasta, gravies and sauces, nuts and nut products, and soft candy. At this time, there is little supporting evidence to accompany claims that these, or other fat substitutes, are hazardous; however, more long-term research is needed.
- "Position of the American Dietetic Association: Fat replacers". Journal of the American Dietetic Association. 105 (2): 266–275. 2005. doi:10.1016/j.jada.2004.12.011.
- "Fat Replacers". Calorie Control Council. Retrieved 9 November 2011.
- "The Surgeon General's Report on Nutrition and Health". U.S. Department of Health and Human Services, Public Health Service. DHHS Publication No. 88-50211. 1988.
- Borra, Susan. "Fat Substitutes". Retrieved 11 Nov 2011.
- "Guidance for Industry: Frequently Asked Questions About GRAS". U.S. Food and Drug Administration. Archived from the original on 6 June 2009. Retrieved 11 Nov 2011.
- Mcrorie; Brown; Cooper; Givaruangsawat; Scruggs; Boring (2000-04-01). "Effects of dietary fibre and olestra on regional apparent viscosity and water content of digesta residue in porcine large intestine". Alimentary Pharmacology & Therapeutics. 14 (4): 471–477. doi:10.1046/j.1365-2036.2000.00734.x. ISSN 1365-2036.
- "Epogee aims to take bite out of fat-substitute market". Crain's Indianapolis. 2016-11-10. Retrieved 2017-06-06.
- "GRAS Notices". www.accessdata.fda.gov. Retrieved 2017-06-05.